US20110304131A1 - Labeling and verifying an item with an identifier - Google Patents
Labeling and verifying an item with an identifier Download PDFInfo
- Publication number
- US20110304131A1 US20110304131A1 US13/158,254 US201113158254A US2011304131A1 US 20110304131 A1 US20110304131 A1 US 20110304131A1 US 201113158254 A US201113158254 A US 201113158254A US 2011304131 A1 US2011304131 A1 US 2011304131A1
- Authority
- US
- United States
- Prior art keywords
- label
- tag
- identifier
- item
- information
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000002372 labelling Methods 0.000 title description 3
- 238000004519 manufacturing process Methods 0.000 claims abstract description 6
- 230000003595 spectral effect Effects 0.000 claims description 11
- 239000004615 ingredient Substances 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 239000000865 liniment Substances 0.000 claims description 4
- 235000016709 nutrition Nutrition 0.000 claims description 3
- 230000035764 nutrition Effects 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- 241000021559 Dicerandra Species 0.000 claims description 2
- 235000010654 Melissa officinalis Nutrition 0.000 claims description 2
- 239000007894 caplet Substances 0.000 claims description 2
- 239000002775 capsule Substances 0.000 claims description 2
- 239000006071 cream Substances 0.000 claims description 2
- 239000013078 crystal Substances 0.000 claims description 2
- 239000006210 lotion Substances 0.000 claims description 2
- 239000002674 ointment Substances 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- 239000010409 thin film Substances 0.000 claims description 2
- 229940040145 liniment Drugs 0.000 claims 1
- 239000003550 marker Substances 0.000 description 29
- 239000003814 drug Substances 0.000 description 16
- 238000010586 diagram Methods 0.000 description 14
- 239000000047 product Substances 0.000 description 13
- 238000001228 spectrum Methods 0.000 description 12
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 8
- 229940079593 drug Drugs 0.000 description 8
- 238000000034 method Methods 0.000 description 7
- 230000036541 health Effects 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 239000000284 extract Substances 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 238000004806 packaging method and process Methods 0.000 description 4
- 239000000377 silicon dioxide Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 3
- -1 etc.) Substances 0.000 description 3
- 238000005286 illumination Methods 0.000 description 3
- 239000006187 pill Substances 0.000 description 3
- 238000000275 quality assurance Methods 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000004590 computer program Methods 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 238000009877 rendering Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 238000012356 Product development Methods 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000005530 etching Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 235000021474 generally recognized As safe (food) Nutrition 0.000 description 1
- 235000021472 generally recognized as safe Nutrition 0.000 description 1
- 235000021473 generally recognized as safe (food ingredients) Nutrition 0.000 description 1
- 239000000976 ink Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002086 nanomaterial Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000006186 oral dosage form Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000011170 pharmaceutical development Methods 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000002310 reflectometry Methods 0.000 description 1
- 230000033458 reproduction Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000004557 technical material Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000002966 varnish Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G09—EDUCATION; CRYPTOGRAPHY; DISPLAY; ADVERTISING; SEALS
- G09F—DISPLAYING; ADVERTISING; SIGNS; LABELS OR NAME-PLATES; SEALS
- G09F3/00—Labels, tag tickets, or similar identification or indication means; Seals; Postage or like stamps
- G09F3/02—Forms or constructions
- G09F3/0297—Forms or constructions including a machine-readable marking, e.g. a bar code
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B42—BOOKBINDING; ALBUMS; FILES; SPECIAL PRINTED MATTER
- B42D—BOOKS; BOOK COVERS; LOOSE LEAVES; PRINTED MATTER CHARACTERISED BY IDENTIFICATION OR SECURITY FEATURES; PRINTED MATTER OF SPECIAL FORMAT OR STYLE NOT OTHERWISE PROVIDED FOR; DEVICES FOR USE THEREWITH AND NOT OTHERWISE PROVIDED FOR; MOVABLE-STRIP WRITING OR READING APPARATUS
- B42D25/00—Information-bearing cards or sheet-like structures characterised by identification or security features; Manufacture thereof
- B42D25/20—Information-bearing cards or sheet-like structures characterised by identification or security features; Manufacture thereof characterised by a particular use or purpose
- B42D25/22—Information-bearing cards or sheet-like structures characterised by identification or security features; Manufacture thereof characterised by a particular use or purpose for use in combination with accessories specially adapted for information-bearing cards
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B42—BOOKBINDING; ALBUMS; FILES; SPECIAL PRINTED MATTER
- B42D—BOOKS; BOOK COVERS; LOOSE LEAVES; PRINTED MATTER CHARACTERISED BY IDENTIFICATION OR SECURITY FEATURES; PRINTED MATTER OF SPECIAL FORMAT OR STYLE NOT OTHERWISE PROVIDED FOR; DEVICES FOR USE THEREWITH AND NOT OTHERWISE PROVIDED FOR; MOVABLE-STRIP WRITING OR READING APPARATUS
- B42D25/00—Information-bearing cards or sheet-like structures characterised by identification or security features; Manufacture thereof
- B42D25/20—Information-bearing cards or sheet-like structures characterised by identification or security features; Manufacture thereof characterised by a particular use or purpose
- B42D25/28—Information-bearing cards or sheet-like structures characterised by identification or security features; Manufacture thereof characterised by a particular use or purpose for use in medical treatment or therapy
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
- G16H20/13—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered from dispensers
Definitions
- a producer or reseller of items (including ingredients and components of such items)—for example a manufacturer, but also including other parties in the entire supply and distribution chain such as a supplier, a wholesaler, a distributor, a repackager, and a retailer—especially, but not limited to, high-value items, faces counterfeiting of the item.
- Counterfeiting includes the substitution, dilution, addition or omission of ingredients or components of the item compared to its intended product specification, as well as misrepresentation or diversion of the packaged item from its intended course of sale. This leads to loss of potential revenue as counterfeit items are sold in the place of the real item.
- the counterfeit can perform differently or not at all as compared to an authentic item. This is particularly acute in industries that can affect health and safety such as industries involved with pharmaceuticals, nutritional supplements, medical devices, food and beverages, construction, transportation, and defense.
- items that appear physically identical or similar may actually contain different ingredients or components, but because of similar appearance may be unintentionally packaged or labeled incorrectly. Even if the items are otherwise identical, they may have different properties associated with the particular lot or batch conditions; for example, pharmaceuticals that otherwise appear identical may have different expiration dates and be incorrectly labeled due to failures or limitations in quality assurance protocols to ascertain such differences.
- item-level identity error may be introduced, for example, at the contract research organization that repackages the various product formulations into masked unit-doses. Much time, cost, and effort goes into statistical sampling and chemical analyses to verify the true identity of the unit-doses that are ultimately administered.
- FIG. 1 is a block diagram illustrating an embodiment of a package producer.
- FIG. 2 is a block diagram illustrating an embodiment of a labeler.
- FIG. 3 is a block diagram illustrating an embodiment of a reader.
- FIG. 4 is a block diagram illustrating an embodiment of a Marker UID computer.
- FIG. 5 is a block diagram illustrating an embodiment of a digital signature computer.
- FIG. 6 is a block diagram illustrating an embodiment of a label writer.
- FIG. 7 is a block diagram illustrating an embodiment of a verifier.
- the invention can be implemented in numerous ways, including as a process; an apparatus; a system; a composition of matter; a computer program product embodied on a computer readable storage medium; and/or a processor, such as a processor configured to execute instructions stored on and/or provided by a memory coupled to the processor.
- these implementations, or any other form that the invention may take, may be referred to as techniques.
- the order of the steps of disclosed processes may be altered within the scope of the invention.
- a component such as a processor or a memory described as being configured to perform a task may be implemented as a general component that is temporarily configured to perform the task at a given time or a specific component that is manufactured to perform the task.
- the term ‘processor’ refers to one or more devices, circuits, and/or processing cores configured to process data, such as computer program instructions.
- a system for labeling and verifying an item with an identifier comprises a package producer and a verifier.
- the package producer produces a package with a label.
- the package includes one or more items each with an associated one or more selected tag identifiers that are placed in a location on the item.
- the verifier verifies the one or more items using 1) the associated one or more selected tag identifiers as detected using a spectral measurement or 2) the location and/or shape of the tag identifiers on the item as detected using an imager, and 3) the label as read using a label reader.
- the package contains individually identified items, the package contains one type of item identified with an identifier for the one type of item, or any other appropriate mapping of identifier(s) and/or item type, or any appropriate item or type of item.
- each item e.g., an individual art piece
- each type of item e.g., all art pieces of a series of art pieces, a series of lithographic reproductions, etc.
- each type of item e.g., all art pieces of a series of art pieces, a series of lithographic reproductions, etc.
- each individual item is identifiable because it has a different tag, or all the items of the same type have the same tag so that the items of the type cannot individually be told apart but instead can be differentiated from other types of items (e.g., vitamin C tablets as opposed to vitamin D, or a low-dose type of medicine opposed to its higher-dose counterpart, etc.).
- other types of items e.g., vitamin C tablets as opposed to vitamin D, or a low-dose type of medicine opposed to its higher-dose counterpart, etc.
- the label is comprised in part of information about the packaged items (hereby denoted goods information or goods info) that is useful to authenticate with the item.
- goods info for medicines may contain dosage information, expiration dates, lot numbers, etc.
- Goods information may comprise different types of information depending on the associated item—for example, ingredient(s), SKU number, identifier, physical characteristic (e.g., weight, dimension, volume, etc.), nutrition information, etc.
- the package comprises a pharmaceutical package that includes one or more solid oral dosage forms (SODFs: e.g., tablets, capsules, caplets, powders, crystals, and thin films, etc.), liquids (e.g., creams, gels, liniments, balms, lotions, injectables, and ointments, etc.), and/or any other appropriate medicines.
- SODFs solid oral dosage forms
- liquids e.g., creams, gels, liniments, balms, lotions, injectables, and ointments, etc.
- the medicines have one or more added tag identifiers that are added into the outer coating, are distributed on the outer layer of an uncoated medicine (e.g., a SODF), are distributed throughout a SODF or liquid, or any other appropriate manner of adding a tag identifier.
- each tag comprises a rugate filter.
- the physical placement is used for identification—for example, the tags are laid out in a pattern (e.g., geometric shape, bar code, etc.) that is detectable using an imaging device.
- the shapes of the tags are characterized and the characterization is used for identification.
- the package comprises a pharmaceutical package that includes one or more pills, liquids, test strips, transdermal patches or any other appropriate medicines or medical devices.
- the medicines have an added tag identifier that is added into the outer coating, is distributed on the outer layer of an uncoated medicine (e.g., a pill), is distributed throughout a pill or liquid, or any other appropriate manner of adding a tag identifier.
- the package comprises an item—for example, an electronic chip, sub-component, medical devices, an automobile or airplane part, building or material supplies, clothing, toys, cosmetics, jewelry, watches, works of art, currency, tickets, official identification documents, wine, or gourmet food.
- the tag comprises a rugate filter.
- the physical placement is used for identification—for example, the tags are laid out in a shape (e.g., a circle, a square, etc.) or pattern (e.g., checkerboard, bar code, etc.) that is detectable using an imaging device.
- the shape or shapes of one or more than one of the tags themselves are characterized and the characterization is used for identification.
- individual tag placement is partially variable due to inclusion of a random or pseudorandom step in the tag placement process, allowing unique or nearly unique tag placement for each cluster of tags.
- the verifier measures the location of one or more tags on an item or label, and from the tag locations and/or shapes produces a signature by means of an algorithm.
- the algorithm uses the relative arrangement and/or shape of multiple tags with or without a fiduciary mark to produce a single item signature.
- the algorithm produces a signature from the location and/or shape of each tag, and then combines the signatures from more than one tag on an item into a single signature.
- the algorithm produces multiple signatures derived from the location and/or shape of one or more tags.
- the verifier produces a single signature from the location and/or shape of one or more tags.
- the use of a tag shape or combination of tag shapes, the placement of one or more tags in a pattern or arrangement or the relative locations of the one or more tags, or the spectral signature of a tag or of more than one tag are used alone or in combination to determine whether or not an item marked with the tag(s) is the authentic item.
- tags are made of the silica (deemed “generally recognized as safe”—or GRAS—by the FDA), rendering them biologically inert and edible.
- Each barely visible tag contains a custom-manufactured spectral signature chosen from over one billion possibilities, yet each item costs only fractions of a penny to label.
- the unique optical signature of each tag can be read by a low cost scanner and be linked to a label in a secure database, where additional information about the item can be stored, such as referencing a future e-pedigree track-and-trace system.
- Tags comprise a silicon wafer that is etched to have a spectral code encoded by the etching.
- the wafer is divided into small tags, and the resultant tags contain a complex porous nanostructure that is programmed during electrochemical synthesis to display a unique reflectivity spectrum.
- the tags are then oxidized by a high-temperature bake step to turn the crystalline, nanoporous silicon tags into amorphous, nanoporous silica. This bake step stabilizes the nanoporous structure against further oxidation (thus stabilizing the spectral signature) and provides for the tags to be characterized as a GRAS excipient.
- the spectrum is measured via a simple, low-cost spectrometer-based reader, then quickly verified against other information printed on the package, such that the medicine and packaging are authenticated together; tampering with either the package, or the contents, would flag a security violation.
- the tags can also be used on their own acting simply as labels for quality assurance or other purposes. Information capacity is projected to potentially reach one trillion possible unique spectra, using peak number, peak placement, peak rugate phase, and/or peak amplitude as modulation parameters.
- the tags are passive, inconspicuous and can be attached to the outside of medicines or food products to be read, for example, through clear or translucent plastic blister packs, or mixed into medicines or food as a forensic excipient, to be read as part of an investigation or inspection process by authorized security or quality assurance personnel.
- the tag properties comprise:
- a system for manufacturing a label comprises a tag reader a computer, and a label writer.
- the tag reader determines an identifier based at least in part on a data read by the tag reader.
- the computer receives an identifier, a key, and a goods information and provides a message authentication code.
- the label writer receives the message authentication code and provides a label.
- FIG. 1 is a block diagram illustrating an embodiment of a package producer.
- package producer 100 comprises identifier adder 102 , labeler 104 , and packager 106 .
- Identifier adder 102 receives an identifier (e.g., tag(s)) and item(s) and adds the identifier to the item(s).
- the identifier adder 102 is part of an item manufacturing system. In some embodiments, the identifier adder 102 is placed prior to or after item manufacturing.
- the item with identifier is measured by labeler 104 for spectral information from the tag, placement information of the tag on the item (e.g., in a pattern, in a code, forming a shape, etc.), and tag shape and/or characteristic information.
- Labeler 104 based on the information detected from the items and/or key and/or goods information, generates a label for a package for the item. Label is added to the package using packager 106 . In some embodiments, labeler 104 also sends some or all information to a database handler.
- FIG. 2 is a block diagram illustrating an embodiment of a labeler.
- labeler 200 is used to implement labeler 104 of FIG. 1 .
- labeler 200 comprises reader 202 , marker UID computer 204 , digital signature computer 206 , and label writer 208 .
- Labeler 200 receives item(s) with identifier and goods information and a private key and provides label(s).
- Reader 202 reads identifier associated with item(s).
- Reader 202 reads an item using a plurality of reading methods so that an item's tag and/or an item's placement and/or type of item are read.
- Marker UID computer 204 calculates a marker unique identifier, which comprises information about spectral content, spatial arrangement and/or shape of tags composing the marker.
- Digital signature computer 206 computes a digital signature using goods information (e.g., information regarding the item) and the marker UID. In some embodiments, Digital signature computer 206 is omitted, and the marker UID is passed directly to label writer 208 .
- Label writer 208 writes a label including machine readable (e.g., 1-dimensional and/or 2-dimensional bar codes) and human readable (e.g., an alphanumeric printed codes and/or other printed characters) features and/or symbols.
- FIG. 3 is a block diagram illustrating an embodiment of a reader.
- reader 300 is used to implement reader 202 of FIG. 2 .
- reader 300 comprises illuminator 302 , spectra measurer 304 , and imager 306 .
- Reader 300 examines an item with an identifier and provides an output spectra and image.
- Illuminator 302 illuminates the item enabling the item to be read.
- illuminator 302 illuminates with different illumination for spectra measurer 304 (e.g., broadband illumination), for imager 306 (e.g., white light, monochromatic light, etc.), or any other appropriate illumination.
- spectra measurer 304 e.g., broadband illumination
- imager 306 e.g., white light, monochromatic light, etc.
- Spectra measurer 304 measures the reflectance or transmission spectral response of an item with an identifier. For example, the spectral peaks, their amplitudes (e.g., relative or absolute amplitudes), their frequencies are measured.
- Imager 306 images the item with an identifier—For example, a placement or shape information associated with the tag placed in item (e.g., a shape or a relation to a fiducial). In some embodiments, imager 306 is omitted from reader 300 . In some embodiments, spectra measurer 304 is omitted from reader 300 .
- FIG. 4 is a block diagram illustrating an embodiment of a Marker UID computer.
- marker UID computer 400 is used to implement marker UID computer 204 of FIG. 2 .
- marker UID computer 400 comprises identifier extractor 402 , image fingerprinter 404 , and UID determiner 406 .
- Marker UID computer 400 receives spectra and image information and provides a Marker UID.
- Identifier extractor 402 extracts identifier from spectra information of identifier (e.g., a tag) associated with the item.
- Image fingerprinter 404 extracts information associated with tag shape or placement information.
- UID determiner 406 determines a UID based on identifier extracted from spectra and image extracted information.
- identifier extractor 402 is omitted, and UID determiner 406 uses only the output of image fingerprinter 404 .
- image fingerprinter 404 is omitted, and UID determiner 406 uses only the output of identifier extractor 402 .
- FIG. 5 is a block diagram illustrating an embodiment of a digital signature computer.
- digital signature computer 500 is used to implement digital signature computer 206 of FIG. 2 .
- digital signature computer 500 comprises combiner 502 and message authenticator 504 .
- Digital signature computer 500 receives goods information and marker UID and a key and provides a message authentication code.
- Combiner 502 combines goods information and marker UID.
- Message authenticator 504 digitally signs the output of combiner 502 using a key, and outputs the result.
- FIG. 6 is a block diagram illustrating an embodiment of a label writer.
- label writer is used to implement labeler 104 of FIG. 1 .
- Label writer 600 comprises a label determiner 602 , human readable labeler 604 , and machine readable labeler 606 .
- Label writer 600 receives a marker UID, goods information, message authentication code and provides a human readable label and a machine readable label.
- Label determiner 602 receives a marker UID, goods information, optionally message authentication code and determines a human readable label and a machine readable label.
- Human readable labeler 604 provides a human readable label—for example, a label is produced with alphanumeric codes or an understandable image or combination of the two or with any other appropriate human decodable label.
- Machine readable labeler 606 provides a machine readable label—for example, a label is produced with a 1-d or 2-d barcode.
- label writer 600 also outputs label determiner 602 output to a secure database.
- FIG. 7 is a block diagram illustrating an embodiment of a verifier.
- verifier 700 comprises imager 703 , reader 702 , label reader 704 , item marker UID computer 706 , label marker UID extractor 708 , label digital signature extractor 710 , label goods information extractor 712 , label digital validity determiner 714 , Marker UID validity determiner 716 , and product validity determiner 718 .
- Verifier 700 operates on an item with an identifier and on a package with a label and provides a validity determination.
- Imager 703 and reader 702 extract information by measuring one or more spectra of at least one information tag and an image of the position and/or shape of at least one of the information tags.
- Item marker UID computer 706 receives the information from imager 703 and reader 702 and determines a marker UID.
- Label reader 704 reads an item package label and extracts information.
- Label marker UID extractor 708 receives the information and determines the marker UID.
- Marker UID validity determiner 716 determines the validity of the marker UIDs produced by label marker UID extractor 708 and item marker UID computer 706 .
- Label reader 704 also determines information for label digital signature extractor 710 and label goods information extractor 712 .
- Label digital validity determiner 714 receives information from label goods information extractor 712 , label digital signature extractor 710 , label marker UID extractor 708 , and public key to determine the validity of the digital signature received from label digital signature extractor 710 .
- Product validity determiner 718 receives UID validity and label digital validity information and produces a product validity determination.
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Theoretical Computer Science (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Primary Health Care (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Details Of Rigid Or Semi-Rigid Containers (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Abstract
A system for manufacturing a label comprises a tag reader a computer, and a label writer. The tag reader determines an identifier based at least in part on a data read by the tag reader. The computer receives an identifier, a key, and a goods information and provides a message authentication code. The label writer receives the message authentication code and provides a label.
Description
- This application claims priority to U.S. Provisional Patent Application No. 61/354,639 (Attorney Docket No. CBIOP004+) entitled LABELING AND VERIFYING AN ITEM WITH AN IDENTIFIER filed Jun. 14, 2010 which is incorporated herein by reference for all purposes.
- A producer or reseller of items (including ingredients and components of such items)—for example a manufacturer, but also including other parties in the entire supply and distribution chain such as a supplier, a wholesaler, a distributor, a repackager, and a retailer—especially, but not limited to, high-value items, faces counterfeiting of the item. Counterfeiting includes the substitution, dilution, addition or omission of ingredients or components of the item compared to its intended product specification, as well as misrepresentation or diversion of the packaged item from its intended course of sale. This leads to loss of potential revenue as counterfeit items are sold in the place of the real item. Also, there can be health or product related damages caused by not using an authentic item as opposed to a counterfeit—for example, the counterfeit can perform differently or not at all as compared to an authentic item. This is particularly acute in industries that can affect health and safety such as industries involved with pharmaceuticals, nutritional supplements, medical devices, food and beverages, construction, transportation, and defense.
- As international criminal organizations become more sophisticated, existing packaging security is proving inadequate. The complexity of many industry supply chains—for example, the supply chain of the pharmaceutical industry—lends itself to entry points for adulterated or counterfeit product(s), often found in carefully counterfeited and high-quality packaging, and sometimes in authentic packaging that has either been stolen or as part of a repackaging operation.
- In complex product supply chains and markets with variable pricing, opportunities for arbitrage exist for unscrupulous parties to misrepresent product pricing without any change to the underlying product, and thus benefit monetarily, for example, as in returns, rebate or charge-back fraud. Monetary gain or loss to either side of a transaction may also result from errors in record-keeping.
- In addition to counterfeiting or product misrepresentation, items that appear physically identical or similar, for example certain nutritional supplements, may actually contain different ingredients or components, but because of similar appearance may be unintentionally packaged or labeled incorrectly. Even if the items are otherwise identical, they may have different properties associated with the particular lot or batch conditions; for example, pharmaceuticals that otherwise appear identical may have different expiration dates and be incorrectly labeled due to failures or limitations in quality assurance protocols to ascertain such differences.
- For product development and research, it may be beneficial at times to study and authenticate performance of items that appear identical but are made differently to learn whether or how those differences affect an end use. At times, it is important in such studies—for example in clinically masked (or ‘blind’) studies leading to pharmaceutical development—to be able to confidently identify the underlying item without revealing the true identity to study participants. In the case of pharmaceutical development and clinical trials, item-level identity error may be introduced, for example, at the contract research organization that repackages the various product formulations into masked unit-doses. Much time, cost, and effort goes into statistical sampling and chemical analyses to verify the true identity of the unit-doses that are ultimately administered.
- In the effort to attain positive health outcomes in a more cost-effective and timely manner, healthcare providers need to focus on the adherence to health regimens, not just the efficacy of specific drugs. Understanding when, where and how often medicine is prescribed by a doctor, accurately and timely dispensed from a pharmacy, received by a patient, and consumed by the patient is helpful in understanding and verifying the effectiveness of the overall health regimen. Recording and collecting the data for appropriate analysis and study while also being able to confirm the underlying identity of the medicine at each stage is important to the reliability of the information collected.
- Various embodiments of the invention are disclosed in the following detailed description and the accompanying drawings.
-
FIG. 1 is a block diagram illustrating an embodiment of a package producer. -
FIG. 2 is a block diagram illustrating an embodiment of a labeler. -
FIG. 3 is a block diagram illustrating an embodiment of a reader. -
FIG. 4 is a block diagram illustrating an embodiment of a Marker UID computer. -
FIG. 5 is a block diagram illustrating an embodiment of a digital signature computer. -
FIG. 6 is a block diagram illustrating an embodiment of a label writer. -
FIG. 7 is a block diagram illustrating an embodiment of a verifier. - The invention can be implemented in numerous ways, including as a process; an apparatus; a system; a composition of matter; a computer program product embodied on a computer readable storage medium; and/or a processor, such as a processor configured to execute instructions stored on and/or provided by a memory coupled to the processor. In this specification, these implementations, or any other form that the invention may take, may be referred to as techniques. In general, the order of the steps of disclosed processes may be altered within the scope of the invention. Unless stated otherwise, a component such as a processor or a memory described as being configured to perform a task may be implemented as a general component that is temporarily configured to perform the task at a given time or a specific component that is manufactured to perform the task. As used herein, the term ‘processor’ refers to one or more devices, circuits, and/or processing cores configured to process data, such as computer program instructions.
- A detailed description of one or more embodiments of the invention is provided below along with accompanying figures that illustrate the principles of the invention. The invention is described in connection with such embodiments, but the invention is not limited to any embodiment. The scope of the invention is limited only by the claims and the invention encompasses numerous alternatives, modifications and equivalents. Numerous specific details are set forth in the following description in order to provide a thorough understanding of the invention. These details are provided for the purpose of example and the invention may be practiced according to the claims without some or all of these specific details. For the purpose of clarity, technical material that is known in the technical fields related to the invention has not been described in detail so that the invention is not unnecessarily obscured.
- A system for labeling and verifying an item with an identifier is disclosed. The system comprises a package producer and a verifier. The package producer produces a package with a label. The package includes one or more items each with an associated one or more selected tag identifiers that are placed in a location on the item. The verifier verifies the one or more items using 1) the associated one or more selected tag identifiers as detected using a spectral measurement or 2) the location and/or shape of the tag identifiers on the item as detected using an imager, and 3) the label as read using a label reader.
- In various embodiments, the package contains individually identified items, the package contains one type of item identified with an identifier for the one type of item, or any other appropriate mapping of identifier(s) and/or item type, or any appropriate item or type of item. For example, each item (e.g., an individual art piece) has an individually identifiable set of tags or each type of item (e.g., all art pieces of a series of art pieces, a series of lithographic reproductions, etc.) has the same tag. So, that either each individual item is identifiable because it has a different tag, or all the items of the same type have the same tag so that the items of the type cannot individually be told apart but instead can be differentiated from other types of items (e.g., vitamin C tablets as opposed to vitamin D, or a low-dose type of medicine opposed to its higher-dose counterpart, etc.).
- In various embodiments, the label is comprised in part of information about the packaged items (hereby denoted goods information or goods info) that is useful to authenticate with the item. For example, goods info for medicines may contain dosage information, expiration dates, lot numbers, etc. Goods information may comprise different types of information depending on the associated item—for example, ingredient(s), SKU number, identifier, physical characteristic (e.g., weight, dimension, volume, etc.), nutrition information, etc.
- In various embodiments, the package comprises a pharmaceutical package that includes one or more solid oral dosage forms (SODFs: e.g., tablets, capsules, caplets, powders, crystals, and thin films, etc.), liquids (e.g., creams, gels, liniments, balms, lotions, injectables, and ointments, etc.), and/or any other appropriate medicines. The medicines have one or more added tag identifiers that are added into the outer coating, are distributed on the outer layer of an uncoated medicine (e.g., a SODF), are distributed throughout a SODF or liquid, or any other appropriate manner of adding a tag identifier. In some embodiments, each tag comprises a rugate filter. In some embodiments, the physical placement is used for identification—for example, the tags are laid out in a pattern (e.g., geometric shape, bar code, etc.) that is detectable using an imaging device. In some embodiments, the shapes of the tags are characterized and the characterization is used for identification.
- In various embodiments, the package comprises a pharmaceutical package that includes one or more pills, liquids, test strips, transdermal patches or any other appropriate medicines or medical devices. The medicines have an added tag identifier that is added into the outer coating, is distributed on the outer layer of an uncoated medicine (e.g., a pill), is distributed throughout a pill or liquid, or any other appropriate manner of adding a tag identifier. In various embodiments, the package comprises an item—for example, an electronic chip, sub-component, medical devices, an automobile or airplane part, building or material supplies, clothing, toys, cosmetics, jewelry, watches, works of art, currency, tickets, official identification documents, wine, or gourmet food. In some embodiments, the tag comprises a rugate filter. In some embodiments, the physical placement is used for identification—for example, the tags are laid out in a shape (e.g., a circle, a square, etc.) or pattern (e.g., checkerboard, bar code, etc.) that is detectable using an imaging device. In some embodiments, the shape or shapes of one or more than one of the tags themselves are characterized and the characterization is used for identification. In some embodiments, individual tag placement is partially variable due to inclusion of a random or pseudorandom step in the tag placement process, allowing unique or nearly unique tag placement for each cluster of tags. In some embodiments, the verifier measures the location of one or more tags on an item or label, and from the tag locations and/or shapes produces a signature by means of an algorithm. In some embodiments, the algorithm uses the relative arrangement and/or shape of multiple tags with or without a fiduciary mark to produce a single item signature. In some embodiments, the algorithm produces a signature from the location and/or shape of each tag, and then combines the signatures from more than one tag on an item into a single signature. In some embodiments, the algorithm produces multiple signatures derived from the location and/or shape of one or more tags. In some embodiments, the verifier produces a single signature from the location and/or shape of one or more tags. For example, the use of a tag shape or combination of tag shapes, the placement of one or more tags in a pattern or arrangement or the relative locations of the one or more tags, or the spectral signature of a tag or of more than one tag are used alone or in combination to determine whether or not an item marked with the tag(s) is the authentic item.
- In some embodiments, tags are made of the silica (deemed “generally recognized as safe”—or GRAS—by the FDA), rendering them biologically inert and edible. Each barely visible tag contains a custom-manufactured spectral signature chosen from over one billion possibilities, yet each item costs only fractions of a penny to label. The unique optical signature of each tag can be read by a low cost scanner and be linked to a label in a secure database, where additional information about the item can be stored, such as referencing a future e-pedigree track-and-trace system. Tags comprise a silicon wafer that is etched to have a spectral code encoded by the etching. The wafer is divided into small tags, and the resultant tags contain a complex porous nanostructure that is programmed during electrochemical synthesis to display a unique reflectivity spectrum. The tags are then oxidized by a high-temperature bake step to turn the crystalline, nanoporous silicon tags into amorphous, nanoporous silica. This bake step stabilizes the nanoporous structure against further oxidation (thus stabilizing the spectral signature) and provides for the tags to be characterized as a GRAS excipient. The spectrum is measured via a simple, low-cost spectrometer-based reader, then quickly verified against other information printed on the package, such that the medicine and packaging are authenticated together; tampering with either the package, or the contents, would flag a security violation. The tags can also be used on their own acting simply as labels for quality assurance or other purposes. Information capacity is projected to potentially reach one trillion possible unique spectra, using peak number, peak placement, peak rugate phase, and/or peak amplitude as modulation parameters. The tags are passive, inconspicuous and can be attached to the outside of medicines or food products to be read, for example, through clear or translucent plastic blister packs, or mixed into medicines or food as a forensic excipient, to be read as part of an investigation or inspection process by authorized security or quality assurance personnel.
- In some embodiments, the tag properties comprise:
- More than one billion codes available
- Inconspicuous size range (20 μm to 150 μm) allows covert or semi-covert use
- Made from clear, high purity silica rendering them biologically inert and edible
- High temperature resistance—melting point above 1600° C.
- Passive—no energy input or output
- Can be used in or on a product, package, label, or security fiber
- Can be applied via sprays, coatings, inks, varnishes, or as part of laminate
- Can be integrated at a number of manufacturing stages—will not slow FDA approvals
- High level of security possible using random tag shapes; security can be scaled to suit specific product needs
- Can be made self-authenticating and reduce the costs and security risks associated with online databases and maintenance
- Each piece of the silica microtag contains the coded information, useful for forensics
- In some embodiments, a system for manufacturing a label comprises a tag reader a computer, and a label writer. The tag reader determines an identifier based at least in part on a data read by the tag reader. The computer receives an identifier, a key, and a goods information and provides a message authentication code. The label writer receives the message authentication code and provides a label.
-
FIG. 1 is a block diagram illustrating an embodiment of a package producer. In the example shown,package producer 100 comprisesidentifier adder 102,labeler 104, andpackager 106.Identifier adder 102 receives an identifier (e.g., tag(s)) and item(s) and adds the identifier to the item(s). In some embodiments, theidentifier adder 102 is part of an item manufacturing system. In some embodiments, theidentifier adder 102 is placed prior to or after item manufacturing. The item with identifier is measured bylabeler 104 for spectral information from the tag, placement information of the tag on the item (e.g., in a pattern, in a code, forming a shape, etc.), and tag shape and/or characteristic information.Labeler 104, based on the information detected from the items and/or key and/or goods information, generates a label for a package for the item. Label is added to thepackage using packager 106. In some embodiments,labeler 104 also sends some or all information to a database handler. -
FIG. 2 is a block diagram illustrating an embodiment of a labeler. In some embodiments,labeler 200 is used to implementlabeler 104 ofFIG. 1 . In the example shown,labeler 200 comprisesreader 202,marker UID computer 204,digital signature computer 206, andlabel writer 208.Labeler 200 receives item(s) with identifier and goods information and a private key and provides label(s).Reader 202 reads identifier associated with item(s).Reader 202 reads an item using a plurality of reading methods so that an item's tag and/or an item's placement and/or type of item are read.Marker UID computer 204 calculates a marker unique identifier, which comprises information about spectral content, spatial arrangement and/or shape of tags composing the marker.Digital signature computer 206 computes a digital signature using goods information (e.g., information regarding the item) and the marker UID. In some embodiments,Digital signature computer 206 is omitted, and the marker UID is passed directly tolabel writer 208.Label writer 208 writes a label including machine readable (e.g., 1-dimensional and/or 2-dimensional bar codes) and human readable (e.g., an alphanumeric printed codes and/or other printed characters) features and/or symbols. -
FIG. 3 is a block diagram illustrating an embodiment of a reader. In some embodiments,reader 300 is used to implementreader 202 ofFIG. 2 . In the example shown,reader 300 comprisesilluminator 302,spectra measurer 304, andimager 306.Reader 300 examines an item with an identifier and provides an output spectra and image.Illuminator 302 illuminates the item enabling the item to be read. In various embodiments,illuminator 302 illuminates with different illumination for spectra measurer 304 (e.g., broadband illumination), for imager 306 (e.g., white light, monochromatic light, etc.), or any other appropriate illumination.Spectra measurer 304 measures the reflectance or transmission spectral response of an item with an identifier. For example, the spectral peaks, their amplitudes (e.g., relative or absolute amplitudes), their frequencies are measured.Imager 306 images the item with an identifier—For example, a placement or shape information associated with the tag placed in item (e.g., a shape or a relation to a fiducial). In some embodiments,imager 306 is omitted fromreader 300. In some embodiments,spectra measurer 304 is omitted fromreader 300. -
FIG. 4 is a block diagram illustrating an embodiment of a Marker UID computer. In some embodiments,marker UID computer 400 is used to implementmarker UID computer 204 ofFIG. 2 . In the example shown,marker UID computer 400 comprisesidentifier extractor 402,image fingerprinter 404, andUID determiner 406.Marker UID computer 400 receives spectra and image information and provides a Marker UID.Identifier extractor 402 extracts identifier from spectra information of identifier (e.g., a tag) associated with the item.Image fingerprinter 404 extracts information associated with tag shape or placement information.UID determiner 406 determines a UID based on identifier extracted from spectra and image extracted information. In some embodiments,identifier extractor 402 is omitted, andUID determiner 406 uses only the output ofimage fingerprinter 404. In some embodiments,image fingerprinter 404 is omitted, andUID determiner 406 uses only the output ofidentifier extractor 402. -
FIG. 5 is a block diagram illustrating an embodiment of a digital signature computer. In some embodiments,digital signature computer 500 is used to implementdigital signature computer 206 ofFIG. 2 . In the example shown,digital signature computer 500 comprisescombiner 502 andmessage authenticator 504.Digital signature computer 500 receives goods information and marker UID and a key and provides a message authentication code.Combiner 502 combines goods information and marker UID.Message authenticator 504 digitally signs the output ofcombiner 502 using a key, and outputs the result. -
FIG. 6 is a block diagram illustrating an embodiment of a label writer. In some embodiments, in 600 label writer is used to implementlabeler 104 ofFIG. 1 .Label writer 600 comprises alabel determiner 602, humanreadable labeler 604, and machinereadable labeler 606.Label writer 600 receives a marker UID, goods information, message authentication code and provides a human readable label and a machine readable label.Label determiner 602 receives a marker UID, goods information, optionally message authentication code and determines a human readable label and a machine readable label. Humanreadable labeler 604 provides a human readable label—for example, a label is produced with alphanumeric codes or an understandable image or combination of the two or with any other appropriate human decodable label. Machinereadable labeler 606 provides a machine readable label—for example, a label is produced with a 1-d or 2-d barcode. In some embodiments,label writer 600 also outputslabel determiner 602 output to a secure database. -
FIG. 7 is a block diagram illustrating an embodiment of a verifier. In the example shown,verifier 700 comprisesimager 703,reader 702,label reader 704, itemmarker UID computer 706, labelmarker UID extractor 708, labeldigital signature extractor 710, labelgoods information extractor 712, labeldigital validity determiner 714, MarkerUID validity determiner 716, andproduct validity determiner 718.Verifier 700 operates on an item with an identifier and on a package with a label and provides a validity determination.Imager 703 andreader 702 extract information by measuring one or more spectra of at least one information tag and an image of the position and/or shape of at least one of the information tags. Itemmarker UID computer 706 receives the information fromimager 703 andreader 702 and determines a marker UID.Label reader 704 reads an item package label and extracts information. Labelmarker UID extractor 708 receives the information and determines the marker UID. MarkerUID validity determiner 716 determines the validity of the marker UIDs produced by labelmarker UID extractor 708 and itemmarker UID computer 706.Label reader 704 also determines information for labeldigital signature extractor 710 and labelgoods information extractor 712. Labeldigital validity determiner 714 receives information from labelgoods information extractor 712, labeldigital signature extractor 710, labelmarker UID extractor 708, and public key to determine the validity of the digital signature received from labeldigital signature extractor 710.Product validity determiner 718 receives UID validity and label digital validity information and produces a product validity determination. - Although the foregoing embodiments have been described in some detail for purposes of clarity of understanding, the invention is not limited to the details provided. There are many alternative ways of implementing the invention. The disclosed embodiments are illustrative and not restrictive.
Claims (20)
1. A system for manufacturing a label, comprising:
A tag reader, wherein the tag reader determines an identifier based at least in part on a data read by the tag reader;
A computer, wherein the computer receives an identifier, a key, and a goods information and provides a message authentication code; and
A label writer, wherein the label writer receives the message authentication code and provides a label.
2. A system as in claim 1 , wherein the identifier is based at least in part on a spectral content of a tag.
3. A system as in claim 1 , wherein the identifier is based at least in part on a spatial arrangement of one tag or more than one tag.
4. A system as in claim 1 , wherein the identifier is based at least in part on a shape, or shapes, of one tag or more than one tag.
5. A system as in claim 1 , wherein the goods information an ingredient.
6. A system as in claim 1 , wherein the goods information a SKU number.
7. A system as in claim 1 , wherein the goods information a physical characteristic.
8. A system as in claim 1 , wherein the goods information a nutrition information.
9. A label, comprising:
a label, wherein the label is added to a package of one or more items, and wherein the label has a portion that is readable by a human being and a portion that is readable by a machine, and wherein label comprises information based at least in part on an identifier, a key, and a goods information.
10. A label as in claim 9 , wherein the identifier is based at least in part on a spectral content of a tag.
11. A label as in claim 9 , wherein the identifier is based at least in part on a spatial arrangement of one tag or more than one tag.
12. A label as in claim 9 , wherein the identifier is based at least in part on a shape of a tag or shapes of more than one tag.
13. A label as in claim 9 , wherein the goods information an ingredient.
14. A label as in claim 9 , wherein the goods information a SKU number.
15. A label as in claim 9 , wherein the goods information a physical characteristic.
16. A label as in claim 9 , wherein the goods information a nutrition information.
17. A label as in claim 9 , wherein one of the one or more items comprises a SODF.
18. A label as in claim 17 , wherein the SODF comprises one of the following: a tablet, a capsule, a caplet, a powder, a crystal, or a thin film.
19. A label as in claim 9 , wherein one of the one or more items comprises a liquid.
20. A label as in claim 19 , wherein the liquid comprises one of the following: a cream, a gel, a liniment, a balm, a lotion, an injectable, or an ointment.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/158,254 US20110304131A1 (en) | 2010-06-14 | 2011-06-10 | Labeling and verifying an item with an identifier |
US15/423,337 US10490108B2 (en) | 2010-06-14 | 2017-02-02 | Item label with a tag |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35463910P | 2010-06-14 | 2010-06-14 | |
US13/158,254 US20110304131A1 (en) | 2010-06-14 | 2011-06-10 | Labeling and verifying an item with an identifier |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/423,337 Division US10490108B2 (en) | 2010-06-14 | 2017-02-02 | Item label with a tag |
Publications (1)
Publication Number | Publication Date |
---|---|
US20110304131A1 true US20110304131A1 (en) | 2011-12-15 |
Family
ID=45095624
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/158,254 Abandoned US20110304131A1 (en) | 2010-06-14 | 2011-06-10 | Labeling and verifying an item with an identifier |
US15/423,337 Active US10490108B2 (en) | 2010-06-14 | 2017-02-02 | Item label with a tag |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/423,337 Active US10490108B2 (en) | 2010-06-14 | 2017-02-02 | Item label with a tag |
Country Status (4)
Country | Link |
---|---|
US (2) | US20110304131A1 (en) |
EP (1) | EP2580688A4 (en) |
CN (1) | CN103080923B (en) |
WO (1) | WO2011159337A1 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20180211207A1 (en) * | 2015-10-08 | 2018-07-26 | Stora Enso Oyj | System and method for tracking products in open-loop supply or value chain |
US10175199B2 (en) | 2012-11-15 | 2019-01-08 | Micro-Tracers, Inc. | Tracer particles, and methods for making same |
WO2020102688A3 (en) * | 2018-11-16 | 2020-08-13 | Facet Labs, Llc | Computing systems for authenticating products using markers and related methods and devices |
CN112288052A (en) * | 2020-09-30 | 2021-01-29 | 深圳市北斗云信息技术有限公司 | Anti-counterfeiting identification method, device and system for concrete test block |
DE102019007434A1 (en) * | 2019-10-25 | 2021-04-29 | Sata Gmbh & Co. Kg | Label for application to a product, method for assigning a specific value to a reward value code within the label and system for assigning a value to the reward value code |
US11094407B2 (en) * | 2019-06-13 | 2021-08-17 | International Business Machines Corporation | Electronics miniaturization platform for medication verification and tracking |
US20220343337A1 (en) * | 2021-04-27 | 2022-10-27 | Carlos Eduardo Bernini KAPINS | Method implemented in computer program for verification of conformity and/or authenticity of an article |
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8802183B2 (en) | 2005-04-28 | 2014-08-12 | Proteus Digital Health, Inc. | Communication system with enhanced partial power source and method of manufacturing same |
US9198608B2 (en) | 2005-04-28 | 2015-12-01 | Proteus Digital Health, Inc. | Communication system incorporated in a container |
US8836513B2 (en) | 2006-04-28 | 2014-09-16 | Proteus Digital Health, Inc. | Communication system incorporated in an ingestible product |
EP2392258B1 (en) | 2005-04-28 | 2014-10-08 | Proteus Digital Health, Inc. | Pharma-informatics system |
US8912908B2 (en) | 2005-04-28 | 2014-12-16 | Proteus Digital Health, Inc. | Communication system with remote activation |
US8547248B2 (en) | 2005-09-01 | 2013-10-01 | Proteus Digital Health, Inc. | Implantable zero-wire communications system |
KR101568660B1 (en) | 2006-05-02 | 2015-11-12 | 프로테우스 디지털 헬스, 인코포레이티드 | Patient customized therapeutic regimens |
EP2083680B1 (en) | 2006-10-25 | 2016-08-10 | Proteus Digital Health, Inc. | Controlled activation ingestible identifier |
EP2069004A4 (en) | 2006-11-20 | 2014-07-09 | Proteus Digital Health Inc | Active signal processing personal health signal receivers |
US8858432B2 (en) | 2007-02-01 | 2014-10-14 | Proteus Digital Health, Inc. | Ingestible event marker systems |
EP2111661B1 (en) | 2007-02-14 | 2017-04-12 | Proteus Digital Health, Inc. | In-body power source having high surface area electrode |
WO2008112578A1 (en) | 2007-03-09 | 2008-09-18 | Proteus Biomedical, Inc. | In-body device having a deployable antenna |
US8932221B2 (en) | 2007-03-09 | 2015-01-13 | Proteus Digital Health, Inc. | In-body device having a multi-directional transmitter |
US8540632B2 (en) | 2007-05-24 | 2013-09-24 | Proteus Digital Health, Inc. | Low profile antenna for in body device |
ES2928197T3 (en) | 2007-09-25 | 2022-11-16 | Otsuka Pharma Co Ltd | Intracorporeal device with virtual dipole signal amplification |
DK2215726T3 (en) | 2007-11-27 | 2018-04-09 | Proteus Digital Health Inc | Transbody communication modules with communication channels |
JP2011513865A (en) | 2008-03-05 | 2011-04-28 | プロテウス バイオメディカル インコーポレイテッド | Multi-mode communication ingestible event marker and system and method of using the same |
ES2696984T3 (en) | 2008-07-08 | 2019-01-21 | Proteus Digital Health Inc | Ingestion event marker data infrastructure |
AU2009281876B2 (en) | 2008-08-13 | 2014-05-22 | Proteus Digital Health, Inc. | Ingestible circuitry |
JP2012511961A (en) | 2008-12-11 | 2012-05-31 | プロテウス バイオメディカル インコーポレイテッド | Judgment of digestive tract function using portable visceral electrical recording system and method using the same |
SG196787A1 (en) | 2009-01-06 | 2014-02-13 | Proteus Digital Health Inc | Ingestion-related biofeedback and personalized medical therapy method and system |
TWI602561B (en) | 2009-01-06 | 2017-10-21 | 波提亞斯數位康健公司 | Pharmaceutical dosages delivery system |
US8540664B2 (en) | 2009-03-25 | 2013-09-24 | Proteus Digital Health, Inc. | Probablistic pharmacokinetic and pharmacodynamic modeling |
SG10201810784SA (en) | 2009-04-28 | 2018-12-28 | Proteus Digital Health Inc | Highly Reliable Ingestible Event Markers And Methods For Using The Same |
EP2432458A4 (en) | 2009-05-12 | 2014-02-12 | Proteus Digital Health Inc | Ingestible event markers comprising an ingestible component |
EP2467707A4 (en) | 2009-08-21 | 2014-12-17 | Proteus Digital Health Inc | Apparatus and method for measuring biochemical parameters |
TWI517050B (en) | 2009-11-04 | 2016-01-11 | 普羅托斯數位健康公司 | System for supply chain management |
UA109424C2 (en) | 2009-12-02 | 2015-08-25 | PHARMACEUTICAL PRODUCT, PHARMACEUTICAL TABLE WITH ELECTRONIC MARKER AND METHOD OF MANUFACTURING PHARMACEUTICAL TABLETS | |
BR112012025650A2 (en) | 2010-04-07 | 2020-08-18 | Proteus Digital Health, Inc. | miniature ingestible device |
TWI557672B (en) | 2010-05-19 | 2016-11-11 | 波提亞斯數位康健公司 | Computer system and computer-implemented method to track medication from manufacturer to a patient, apparatus and method for confirming delivery of medication to a patient, patient interface device |
EP2642983A4 (en) | 2010-11-22 | 2014-03-12 | Proteus Digital Health Inc | Ingestible device with pharmaceutical product |
WO2015112603A1 (en) | 2014-01-21 | 2015-07-30 | Proteus Digital Health, Inc. | Masticable ingestible product and communication system therefor |
US9756874B2 (en) | 2011-07-11 | 2017-09-12 | Proteus Digital Health, Inc. | Masticable ingestible product and communication system therefor |
UA118745C2 (en) | 2011-07-21 | 2019-03-11 | Протеус Діджитал Хелс, Інк. | Mobile communication device, system, and method |
US9235683B2 (en) | 2011-11-09 | 2016-01-12 | Proteus Digital Health, Inc. | Apparatus, system, and method for managing adherence to a regimen |
KR20150038038A (en) | 2012-07-23 | 2015-04-08 | 프로테우스 디지털 헬스, 인코포레이티드 | Techniques for manufacturing ingestible event markers comprising an ingestible component |
KR101565013B1 (en) | 2012-10-18 | 2015-11-02 | 프로테우스 디지털 헬스, 인코포레이티드 | Apparatus, system, and method to adaptively optimize power dissipation and broadcast power in a power source for a communication device |
JP2016508529A (en) | 2013-01-29 | 2016-03-22 | プロテウス デジタル ヘルス, インコーポレイテッド | Highly expandable polymer film and composition containing the same |
US11744481B2 (en) | 2013-03-15 | 2023-09-05 | Otsuka Pharmaceutical Co., Ltd. | System, apparatus and methods for data collection and assessing outcomes |
US10175376B2 (en) | 2013-03-15 | 2019-01-08 | Proteus Digital Health, Inc. | Metal detector apparatus, system, and method |
US9796576B2 (en) | 2013-08-30 | 2017-10-24 | Proteus Digital Health, Inc. | Container with electronically controlled interlock |
WO2015054403A1 (en) * | 2013-10-08 | 2015-04-16 | Global Health Transformations, Inc. | Medication adherence system and method |
US10084880B2 (en) | 2013-11-04 | 2018-09-25 | Proteus Digital Health, Inc. | Social media networking based on physiologic information |
US11051543B2 (en) | 2015-07-21 | 2021-07-06 | Otsuka Pharmaceutical Co. Ltd. | Alginate on adhesive bilayer laminate film |
TWI728155B (en) | 2016-07-22 | 2021-05-21 | 日商大塚製藥股份有限公司 | Electromagnetic sensing and detection of ingestible event markers |
CN109963499B (en) | 2016-10-26 | 2022-02-25 | 大冢制药株式会社 | Method for manufacturing capsules with ingestible event markers |
CN109740719B (en) * | 2016-11-19 | 2021-11-12 | 哈尔滨理工大学 | Packaging system with information hiding function |
EP3591642A1 (en) * | 2018-07-02 | 2020-01-08 | UPM Raflatac Oy | Sealing label |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030174326A1 (en) * | 2002-03-12 | 2003-09-18 | Rzasa David M. | System and method for pharmacy validation and inspection |
US6799725B1 (en) * | 1994-08-05 | 2004-10-05 | Robert J. Hess | Micro barcoded pill and identification/medical information retrieval system |
US20060020469A1 (en) * | 2004-07-08 | 2006-01-26 | Rast Rodger H | Apparatus and methods for static and semi-static displays |
US20060118739A1 (en) * | 2003-06-26 | 2006-06-08 | Ncr Corporation | Security markers for marking pharmaceuticals |
US7089420B1 (en) * | 2000-05-24 | 2006-08-08 | Tracer Detection Technology Corp. | Authentication method and system |
US20080129037A1 (en) * | 2006-12-01 | 2008-06-05 | Prime Technology Llc | Tagging items with a security feature |
US20080252066A1 (en) * | 2007-04-12 | 2008-10-16 | Honeywell, Inc. | Method and system for creating and reading multi-color co-planar emissive indicia using printable dyes and pigments |
US20090008924A1 (en) * | 2005-05-11 | 2009-01-08 | Koninklijke Philips Electronics, N.V. | Authenticating banknotes or other physical objects |
US7903338B1 (en) * | 2006-07-08 | 2011-03-08 | Cirrex Systems Llc | Method and system for managing light at an optical interface |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060054682A1 (en) * | 2004-09-07 | 2006-03-16 | Carlos De La Huerga | Method and system for tracking and verifying medication |
US7204421B2 (en) | 2004-10-27 | 2007-04-17 | Symbol Technologies, Inc. | Method of identifying and authenticating products using an identification pattern and a bar code reader |
US20060174129A1 (en) * | 2005-01-31 | 2006-08-03 | Cyril Brignone | Authentication method and system for tagged items |
ATE401622T1 (en) * | 2005-03-08 | 2008-08-15 | Adalbert Gubo | METHOD FOR CHECKING THE INTEGRITY OF MANY INDIVIDUAL PACKAGES |
US8472046B2 (en) * | 2005-03-11 | 2013-06-25 | Avery Dennison Corporation | Printer systems and methods for global tracking of products in supply chains, authentication of products, and connecting with customers both before, during, and after a product sale |
US7581242B1 (en) * | 2005-04-30 | 2009-08-25 | Hewlett-Packard Development Company, L.P. | Authenticating products |
US7543745B1 (en) * | 2005-04-30 | 2009-06-09 | Hewlett-Packard Development Company, L.P. | Package authentication |
US7441704B2 (en) * | 2006-03-03 | 2008-10-28 | Ncr Corporation | System and method for identifying a spatial code |
EP2016447A4 (en) * | 2006-05-11 | 2010-08-04 | Singular Id Pte Ltd | Identification tags, objects adapted to be identified, and related methods, devices and systems |
US7706994B2 (en) * | 2007-04-18 | 2010-04-27 | Leona Ramsden | System and method for rating the nutritional quality of food items |
CN100511272C (en) * | 2007-10-15 | 2009-07-08 | 北京派瑞根科技开发有限公司 | Safety electronic label |
US9053616B2 (en) * | 2010-04-20 | 2015-06-09 | Temptime Corporation | Computing systems and methods for electronically indicating the acceptability of a product |
-
2011
- 2011-06-10 US US13/158,254 patent/US20110304131A1/en not_active Abandoned
- 2011-06-10 EP EP11796078.1A patent/EP2580688A4/en not_active Withdrawn
- 2011-06-10 CN CN201180029287.5A patent/CN103080923B/en not_active Expired - Fee Related
- 2011-06-10 WO PCT/US2011/001062 patent/WO2011159337A1/en active Application Filing
-
2017
- 2017-02-02 US US15/423,337 patent/US10490108B2/en active Active
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6799725B1 (en) * | 1994-08-05 | 2004-10-05 | Robert J. Hess | Micro barcoded pill and identification/medical information retrieval system |
US7089420B1 (en) * | 2000-05-24 | 2006-08-08 | Tracer Detection Technology Corp. | Authentication method and system |
US20030174326A1 (en) * | 2002-03-12 | 2003-09-18 | Rzasa David M. | System and method for pharmacy validation and inspection |
US20060118739A1 (en) * | 2003-06-26 | 2006-06-08 | Ncr Corporation | Security markers for marking pharmaceuticals |
US20060020469A1 (en) * | 2004-07-08 | 2006-01-26 | Rast Rodger H | Apparatus and methods for static and semi-static displays |
US20090008924A1 (en) * | 2005-05-11 | 2009-01-08 | Koninklijke Philips Electronics, N.V. | Authenticating banknotes or other physical objects |
US7903338B1 (en) * | 2006-07-08 | 2011-03-08 | Cirrex Systems Llc | Method and system for managing light at an optical interface |
US20080129037A1 (en) * | 2006-12-01 | 2008-06-05 | Prime Technology Llc | Tagging items with a security feature |
US20080252066A1 (en) * | 2007-04-12 | 2008-10-16 | Honeywell, Inc. | Method and system for creating and reading multi-color co-planar emissive indicia using printable dyes and pigments |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10175199B2 (en) | 2012-11-15 | 2019-01-08 | Micro-Tracers, Inc. | Tracer particles, and methods for making same |
US10684257B2 (en) | 2012-11-15 | 2020-06-16 | Micro-Tracers, Inc. | Tracer particles, and methods for making same |
US20180211207A1 (en) * | 2015-10-08 | 2018-07-26 | Stora Enso Oyj | System and method for tracking products in open-loop supply or value chain |
US10943206B2 (en) * | 2015-10-08 | 2021-03-09 | Stora Enso Oyj | System and method for tracking products in open-loop supply or value chain |
WO2020102688A3 (en) * | 2018-11-16 | 2020-08-13 | Facet Labs, Llc | Computing systems for authenticating products using markers and related methods and devices |
US11094407B2 (en) * | 2019-06-13 | 2021-08-17 | International Business Machines Corporation | Electronics miniaturization platform for medication verification and tracking |
DE102019007434A1 (en) * | 2019-10-25 | 2021-04-29 | Sata Gmbh & Co. Kg | Label for application to a product, method for assigning a specific value to a reward value code within the label and system for assigning a value to the reward value code |
CN112288052A (en) * | 2020-09-30 | 2021-01-29 | 深圳市北斗云信息技术有限公司 | Anti-counterfeiting identification method, device and system for concrete test block |
US20220343337A1 (en) * | 2021-04-27 | 2022-10-27 | Carlos Eduardo Bernini KAPINS | Method implemented in computer program for verification of conformity and/or authenticity of an article |
Also Published As
Publication number | Publication date |
---|---|
US10490108B2 (en) | 2019-11-26 |
WO2011159337A1 (en) | 2011-12-22 |
EP2580688A1 (en) | 2013-04-17 |
CN103080923A (en) | 2013-05-01 |
CN103080923B (en) | 2018-02-27 |
EP2580688A4 (en) | 2017-05-10 |
US20170206809A1 (en) | 2017-07-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10490108B2 (en) | Item label with a tag | |
US11166874B2 (en) | System for producing a packaged item with an identifier | |
US10071843B2 (en) | System for verifying an item in a package | |
US10269022B2 (en) | System for verifying an item in a package using a database | |
Flank | Counterfeits and Medication Errors: Keeping Your Patients Safe |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: TRUTAG TECHNOLOGIES, INC., HAWAII Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:ZHOU, TING;LEARMONTH, TIMOTHY;O'NEILL, MICHAEL P.;AND OTHERS;SIGNING DATES FROM 20110718 TO 20110819;REEL/FRAME:026820/0194 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |
|
AS | Assignment |
Owner name: FIRST-CITIZENS BANK & TRUST COMPANY, CALIFORNIA Free format text: SECURITY INTEREST;ASSIGNOR:TRUTAG TECHNOLOGIES, INC.;REEL/FRAME:066140/0667 Effective date: 20231215 |